• Non-Credit Course
  • Research to Practice
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leadin
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cance
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial produc
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Wendell Yarbrough, MD, MMHC, FACS,
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Dr.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
This lecture is an interactive presentation and discussion to consider barriers to cancer clinical trial enro
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Dr.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Dr. Benyam Muluneh from the UNC Eshelman School of Pharmacy will discuss relevant topics in cancer pharmacy for North Carolina cancer providers, such as adherence to oral anti-cancer therapies, evolving pharmaceutical practice models (e.g. specialized clinics), toxicity measurement and management, access, and other issues.
  • 1.00 Participation
  • Non-Credit Course
  • Research to Practice
Dr.
  • 1.00 Participation

Pages